Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cleidocranial dysplasia (CCD) is a rare skeletal condition characterized by the hypoplasia or absence of collarbones and delayed closure of skull sutures. First formally described in the late 18th century, our understanding of Cleidocranial dysplasia has evolved from simple anatomical observation to the identification of the RUNX2 gene as its primary genetic driver in 1997. When was Cleidocranial dysplasia first discovered? While cases of Cleidocranial dysplasia were noted in ancient skeletons, the first clinical description appeared in 1765 by Martin, who documented the physical features of a man with absent clavicles.
What is the history of Cleidocranial Dysplasia?
History of Cleidocranial Dysplasia: when and how it was discovered, and the milestones in research since, medically reviewed.
Cleidocranial dysplasia (CCD) is a rare skeletal condition characterized by the hypoplasia or absence of collarbones and delayed closure of skull sutures. First formally described in the late 18th century, our understanding of Cleidocranial dysplasia has evolved from simple anatomical observation to the identification of the RUNX2 gene as its primary genetic driver in 1997.
When was Cleidocranial dysplasia first discovered?
While cases of Cleidocranial dysplasia were noted in ancient skeletons, the first clinical description appeared in 1765 by Martin, who documented the physical features of a man with absent clavicles. It was later termed "cleidocranial dysostosis" by Pierre Marie and Paul Sainton in 1898, who provided the first comprehensive, systematic characterization of the condition’s skeletal and dental manifestations.
How has our understanding of Cleidocranial dysplasia evolved?
Historically, Cleidocranial dysplasia was often misdiagnosed or viewed purely as a curiosity of skeletal anatomy. The realization that it is a systemic condition—impacting not just the bones but also the dental development, hearing, and long-term joint health—has shifted the focus of care from purely aesthetic observation to multidisciplinary management.
What role does genetics play in modern diagnosis?
The landscape of Cleidocranial dysplasia changed permanently in 1997 when researchers discovered that mutations in the RUNX2 gene (located on chromosome 6p21) are responsible for the condition. This milestone allowed for:
- Confirmatory genetic testing for families.
- Prenatal diagnostic options for those seeking genetic counseling.
- A deeper understanding of how RUNX2 regulates bone and tooth formation.
How has patient advocacy shaped the history of the condition?
For many years, patients with Cleidocranial dysplasia faced isolation due to the visible nature of the condition. Today, the 89 members of the DiseaseMaps.org community for Cleidocranial dysplasia highlight the shift toward digital advocacy. By sharing experiences, patients have helped medical researchers recognize the importance of early orthodontic intervention and the management of chronic pain, moving the condition into the spotlight of rare disease research.
Next steps
- Consult with a clinical geneticist to discuss genetic testing and family planning.
- Work with an orthodontist experienced in managing the unique dental needs of Cleidocranial dysplasia.
- Join the DiseaseMaps.org community to connect with other patients and caregivers.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Cleidocranial dysplasia.
- Online Mendelian Inheritance in Man (OMIM): Entry #119600.
- Orphanet: Rare disease database for Cleidocranial dysplasia.
- Children’s Craniofacial Association (CCA) resources.
